Covance is a comprehensive, biopharmaceutical drug development services company with preclinical and clinical research operations across the globe. en-us Copyright 2010 Covance Inc. All rights reserved. CRO for Drug Development Services http://www.covance.com/images/img_gfx/covance.gif 175 37 http://www.covance.com/ View Our 2012 Annual Report and 2013 Proxy Statement Mon, 25 Mar 2013 16:00:00 EDT Covance To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference Mon, 13 May 2013 13:28:01 EDT Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million Wed, 01 May 2013 16:01:30 EDT Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients' Increased Asia Pacific Focus Tue, 16 Apr 2013 8:37:32 EDT